Should Private Companies Share More? The Transparency Debate

The debate isn't some abstract policy discussion. It's about where you might park your retirement money, the stability of the market you trust, and whether the next big idea gets suffocated by paperwork before it can breathe. On one side, you have investors and watchdogs yelling into the void, frustrated by the black box that large private companies have become. On the other, founders and CEOs guarding their playbooks, arguing that forced transparency is a tax on innovation and a roadmap for competitors.

Let me be blunt here. Having analyzed both public and private markets for years, the gap in usable information isn't just a gap—it's a canyon. And regular people, even sophisticated ones, are falling into it. This isn't about publishing every email. It's about the core financial and operational data that determines risk. The current "trust us" model from multi-billion dollar private entities is, frankly, naive and dangerous for a mature economy.

Why Investors Demand More From Private Companies

Picture this. You're considering an investment in a late-stage private tech firm through a special fund. The sales pitch is dazzling: hockey-stick growth, total market domination. But when you ask for the basic documents—a detailed P&L, a breakdown of customer concentration, the cap table showing potential dilution—you get a glossy 20-page PDF full of vanity metrics. No hard numbers on burn rate. No clarity on related-party transactions. You're asked to write a check based on vibes.

This is the daily reality. The core argument for more disclosure is risk mitigation. Large private companies now rival public ones in size and systemic importance. Think of SpaceX, Stripe, or a giant like Cargill. Their failure or misconduct wouldn't be a private matter; it would ripple through supply chains, employment, and intertwined financial institutions.

The pain point isn't just for venture capitalists. It trickles down. Pension funds, university endowments, and even your 401(k) manager are increasingly allocating to private markets seeking returns. That's your money moving into a zone with less regulatory sunlight. The lack of information creates an information asymmetry that benefits insiders and punishes everyone else.

The Specific Data Points That Matter

Investors aren't asking for trade secrets. They're asking for the same foundational data that public companies provide, which allows for apples-to-apples comparison and risk assessment.

• Audited Financials: Not just top-line revenue, but gross margins, operating expenses, and cash flow statements. Are they burning cash to buy growth?
• Governance Structure: Who's on the board? Are there special voting rights that neuter common shareholders?
• Related-Party Transactions: Is the company leasing property from the CEO's cousin at above-market rates? This is a classic red flag.
• Major Risk Factors: What's the single point of failure? Over-reliance on one client? A pending lawsuit that could be existential?

Without this, investing becomes speculation. It rewards hype over fundamentals.

The Level Playing Field Argument (And Its Flaws)

Proponents of mandatory disclosure often frame it as a fairness issue. Public companies groan under the weight of Sarbanes-Oxley and quarterly reporting. They argue that giving large private companies a free pass distorts capital allocation. Why go public and face the music if you can stay private, raise limitless capital, and avoid the scrutiny?

There's truth here. The rise of "unicorns" staying private for a decade or more is a direct result of this regulatory arbitrage. But the counter-argument from the private side isn't without merit. They say the public company reporting model is itself broken—it encourages short-termism. CEOs manage to the quarterly earnings call, sacrificing long-term R&D or bold strategies to please analysts.

I've seen this tension firsthand. A founder friend running a biotech firm told me, "If I had to report quarterly, my investors would have killed our decade-long drug discovery project after year three when trials hit a snag. Staying private saved the project."

So, is the goal to drag everyone into the short-term pool? Or to find a smarter, less myopic disclosure standard?

The Real Cost of Disclosure for Companies

Let's talk about the burden. It's not a myth. Compliance costs are real, especially for growing companies. Hiring a CFO-level finance team, engaging a top-tier audit firm, and dedicating legal resources to disclosure isn't cheap. For a bootstrapped or thinly profitable company, this could be the difference between hiring five engineers or not.

More subtly, there's the strategic cost. Detailed disclosure is a gift to competitors. A public breakdown of your geographic revenue tells rivals exactly where to attack. Your R&D spending as a percentage of revenue shows how seriously you're investing in the future. In hyper-competitive sectors, this is competitive intelligence served on a silver platter.

The fear isn't just paranoia. I recall a mid-sized private SaaS company that, through a leaked document, revealed its customer acquisition cost. Within months, two well-funded competitors launched aggressive, targeted campaigns in its most profitable vertical, undercutting them precisely because they knew the economics.

The key is threshold. A five-person startup shouldn't face the same rules as a 5,000-person, billion-dollar behemoth. The debate is really about those behemoths.

A Practical Path Forward: What Balanced Transparency Could Look Like

So, should they be required to share more? My take, forged from seeing both sides lose, is a qualified yes—but with a scalpel, not a sledgehammer. Blanket application of public market rules would be a mistake. We need a tiered, pragmatic approach.

First, the trigger. Regulation should kick in based on a combination of size, reach, and reliance on external capital. Metrics like annual revenue (e.g., over $500M), number of employees (e.g., over 1000), or total capital raised from non-founder sources (e.g., over $200M) could be sensible thresholds. This targets the systemically important players without crushing the little guys.

Second, the format. Instead of quarterly reports, mandate bi-annual or annual detailed disclosures. This reduces the short-term pressure while providing regular checkpoints. The disclosures could be filed with a neutral body like the SEC but not necessarily blasted to every news outlet—making them available to accredited investors and significant counterparties would be a major step forward.

Third, protect genuine secrets. Allow for limited redactions in disclosures for truly proprietary information (e.g., the secret algorithm, the chemical formula), subject to review. This balances transparency with the need to protect the crown jewels that drive innovation.

The goal isn't to turn private companies public. It's to ensure that as they grow to a scale where their actions impact the broader economy and countless stakeholders, a minimum baseline of accountability and informed decision-making is possible. It's about moving from a culture of "just trust me" to one of "here's enough data for you to verify."